23.02.2021 - 14:03 Uhr

Virpax Pharmaceuticals Inc.: Virpax Begins IND Enabling Studies of Envelta

Virpax? Pharmaceuticals Inc.,

484-880-4588

Or

Betsy Brod Affinity Growth Advisorsbetsy.brod@affinitygrowth.com 212-661-2231

SOURCE: Virpax Pharmaceuticals

23.02.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de

Language: English Company: Virpax(R) Pharmaceuticals Inc. 1554 Paoli Pike PA 19380 West Chester

United States Phone: 484.880.4588 E-mail: info@virpaxpharma.com EQS News ID: 1170287 ? End of News DGAP News Service

1170287??23.02.2021?